AI-assisted, human-published
07/23/2025 /Funding Events
Dash Bio Raises $11 Million to Revolutionize Drug Development with Automated Bioanalysis Platform
Dash Bio secures $11 million in additional funding, bringing the total raised capital to $17.5 million, to further develop and expand their cutting-edge bioanalysis platform.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com